[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365995-105":59,"doc-detail-365995-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-cell-sequencing-and-computational-findings-reveal-antiestrogen-receptor-positive-breast-cancer-roles-of-formononetin","Single cell sequencing and computational findings reveal antiestrogen receptor-positive breast cancer roles of formononetin","","Breast cancer incidence remains a major public health concern, with estrogen receptor (ER) signaling driving development and progression and ER-positive tumors showing heterogeneity that contributes to metastasis and therapeutic resistance. The study applies single-cell sequencing analysis combined with network pharmacology to identify formononetin targets and molecular mechanisms in ER-positive breast cancer. Differentially expressed genes are mapped across multiple cell types, and enriched pathways emphasize immune and inflammatory processes, metastatic potential, metabolism, cell proliferation, and gland development.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-sequencing-and-computational-findings-reveal-antiestrogen-receptor-positive-breast-cancer-roles-of-formononetin/365995/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-sequencing-and-computational-findings-reveal-antiestrogen-receptor-positive-breast-cancer-roles-of-formononetin/365995.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why target estrogen receptors in ER-positive breast cancer?","Question",{"text":112,"@type":113},"Estrogen receptors regulate hormone signaling that drives breast cancer development and progression. Targeting ERs is presented as a promising therapeutic strategy for ER-positive tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study investigate formononetin in ER-positive breast cancer?",{"text":117,"@type":113},"It combines single-cell sequencing data analysis with a network pharmacology approach to identify targets and molecular mechanisms of formononetin at the single-cell level.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological themes emerge from the network pharmacology analysis?",{"text":121,"@type":113},"The analysis highlights pathways related to immune and inflammatory responses, metastatic ability, metabolism, cell proliferation, and gland development across different ER-positive breast cancer cell types.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365995,1791168019,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSingle cell sequencing and computational findings reveal antiestrogen receptor-positive breast cancer roles of formononetin  \nBihui Li1,4􀀍, Shuangxi Li2,4, Ruihan Li3, Menzhen Li3 & Zhaoquan Huang3􀀍  \nBreast cancer is the second leading cancer type in women, accounting for 11.6% of all cancers. Recently, its incidence has increased in younger individuals. Estrogen receptors (ERs) play important roles in the development and progression of breast cancer by controlling hormone signaling. Therefore, targeting ERs is one of the most promising therapeutic strategies for treating ER-positive breast cancer. High heterogeneity contributes to the tumorigenicity, metastatic ability, and therapeutic resistance of breast cancer. However, drug discovery studies at the single-cell level are lacking. In the present study, we used single-cell sequencing data analysis, together with a network pharmacology approach, to determine the targets and molecular mechanisms of formononetin in ER-positive breast cancer. Comparative single-cell sequencing analysis identified 3899, 3395, 333, 398, 398, and 17 differentially expressed genes in stromal cells, epithelial cells, fibroblasts, neutrophils, eosinophils, and macrophages, respectively, of ER-positive breast cancer compared with normal breast tissues. Further network pharmacology analysis highlighted the importance of formononetin targets in biological functions and signaling pathways related to immune and inflammatory responses, metastatic ability, metabolism, cell proliferation, and gland development in different ER-positive breast cancer cell types. For the first time, we used a systems biology approach to investigate the targets of formononetin and its anti-ER-positive breast cancer mechanisms at the single-cell level.  \nKeywords Network pharmacology, Formononetin, Estrogen receptor, ER-positive breast cancer, Single cell  \nAccording to the 2022 Global Cancer Statistics, female breast cancer is the second leading disease in terms of incidence rate, accounting for 11.6% of all cancers1. Breast cancer has become a major global public health challenge and is gradually affecting younger individuals. Its incidence among young people in Japan has increased annually2. Breast cancer can be pathologically classified into ductal and lobular carcinomas with cancerous lesions occurring in the ducts and lobules, respectively3. Breast cancer can be caused by multiple factors, such as heredity, environmental exposure, individual differences, and lifestyle4. Among these, hormone receptors, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), are routine indicators of breast cancer treatment and prognostic markers because they are expressed in the vast majority of breast cancers5. ER and PR positivity (ER +/PR +) accounts for two-thirds of all breast cancers6, and these tumors express either ERs or PRs7. Because ER expression is closely related to the proliferation of breast cancer cells, the use of hormone therapy to target ERs has become one of the major treatments for ER-positive breast cancers6. Clinically, breast cancer heterogeneity is associated with the expression of different hormone receptors, which provides different options for breast cancer treatment8. Conventional treatments for breast cancer are not limited to surgical excision, radiotherapy, chemotherapy, and endocrine therapy9. Although these methods have improved the effectiveness of treatment to a certain extent, they have several limitations. For example, endocrine therapy for breast cancer is associated with a risk of drug resistance and recurrence10. Radiotherapy may cause adverse effects in normal tissues and organs. Furthermore, radiotherapy for breast cancer increases the risk of heart disease and myocardial infarction11. Therefore, an indepth understanding of the role of ER in breast cancer tumorig","cbCaipr92bcEEjmA","https://ap.wps.com/l/cbCaipr92bcEEjmA","pdf",6607068,"English","# Background\n# Study Approach and Rationale\n## Single-cell sequencing strategy\n## Network pharmacology framework\n# Biological Findings and Implicated Mechanisms\n## Differentially expressed genes across cell types\n## Enriched immune, inflammatory, metastatic and metabolic pathways","[{\"question\":\"Why target estrogen receptors in ER-positive breast cancer?\",\"answer\":\"Estrogen receptors regulate hormone signaling that drives breast cancer development and progression. Targeting ERs is presented as a promising therapeutic strategy for ER-positive tumors.\"},{\"question\":\"How does the study investigate formononetin in ER-positive breast cancer?\",\"answer\":\"It combines single-cell sequencing data analysis with a network pharmacology approach to identify targets and molecular mechanisms of formononetin at the single-cell level.\"},{\"question\":\"What biological themes emerge from the network pharmacology analysis?\",\"answer\":\"The analysis highlights pathways related to immune and inflammatory responses, metastatic ability, metabolism, cell proliferation, and gland development across different ER-positive breast cancer cell types.\"}]","Single cell sequencing and computational findings reveal antiestrogen receptor-positive breast cancer roles of formononetin | PDF",1790163455,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bcea018511d35c500b5169b175881ed8.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83f23a2fc49e510d67f18d947439565b.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9924c3e8ff2df7d1ebc19fad024f5ee6.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a7cecbc1090418b5e9ac6208afb7151.webp",980,1287]